Condition
TACE clinical trials and research
As of November 12, 2026, Find a Trial lists 6 TACE clinical trials that are recruiting, in China. By phase: Phase 2 (3), Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest TACE clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Predicting post-surgery treatment for liver cancer using AI and whole-slide images | — | Hangzhou, Zhejiang | Recruiting | Feb 18, 2026 |
| H101 Plus TACE for advanced head and neck cancer | Phase 2 | Chengdu, Sichuan | Recruiting | Feb 10, 2026 |
| Comparing DEB-TACE and cTACE for liver cancer after TIPS | Phase 3 | Guangzhou, Guangdong | Recruiting | Jan 7, 2026 |
| Post-surgery radiotherapy plus sintilimab versus TACE for liver cancer with narrow surgical margins | Phase 3 | Beijing | Recruiting | Sep 22, 2025 |
| Treatment for advanced liver cancer using TACE with new medications | Phase 2 | Xiamen, Fujian | Recruiting | Aug 1, 2023 |
| Combining Lenvatinib, Tislelizumab, and TACE for Liver Cancer Treatment | Phase 2 | Hangzhou, Zhejiang | Recruiting | Jun 27, 2023 |
All recruiting trials (6)
-
Predicting post-surgery treatment for liver cancer using AI and whole-slide images
Aims to see if an AI model based on postoperative tissue images and imaging data can help decide if patients with hepatocellular carcinoma should receive adjuvant therapy after surgery.
-
H101 Plus TACE for advanced head and neck cancer
This study tests whether adding H101 to transarterial chemoembolization can help treat recurrent or metastatic head and neck squamous cell carcinoma.
-
Comparing DEB-TACE and cTACE for liver cancer after TIPS
This trial will test whether DEB-TACE or conventional TACE works better and is safer for people with hepatocellular carcinoma beyond Milan criteria who previously had a TIPS.
-
Post-surgery radiotherapy plus sintilimab versus TACE for liver cancer with narrow surgical margins
This trial will try to see if adding radiotherapy and the immunotherapy drug sintilimab after curative liver cancer surgery prevents recurrence better than TACE in patients with narrow surgical margins and other high-risk features.
-
Treatment for advanced liver cancer using TACE with new medications
This study is testing a new treatment combining TACE with two medications to see if it helps people with advanced liver cancer who can't have surgery.
-
Combining Lenvatinib, Tislelizumab, and TACE for Liver Cancer Treatment
This study is testing a new combination treatment for liver cancer to see if it can help patients at high risk of their cancer coming back after surgery.
Related topics
Quick answers
How many TACE clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.